X0306 4 2022-05-17 0 0000818686 TEVA PHARMACEUTICAL INDUSTRIES LTD TEVA 0001561458 Fridriksdottir Hafrun C/O TEVA PHARMACEUTICAL INDUSTRIES LTD. 124 DVORA HANEVI'A ST., TEL AVIV L3 6944020 ISRAEL 0 1 0 0 Executive VP, Global R&D Ordinary Shares 2022-05-17 4 S 0 130000 8.2159 D 1386.514 D The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.185 to $8.240, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price. The shares held by the reporting person prior to the sale reported in this Form 4 included 5,300 Ordinary Shares previously issued to the reporting person in exempt transactions in connection with the settlement of certain equity-based awards granted to the reporting person, which were inadvertently omitted from the reporting person's previously reported amount of securities beneficially owned. /s/ Dov Bergwerk as attorney-in-fact for Hafrun Fridriksdottir 2022-05-19